Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07814365 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PBI for Low-risk Breast Cancer

StatusWithdrawn
PhaseNot applicable
Started2026-09-13
View on ClinicalTrials.gov ↗

Amendment history

2026-09-17
critical
Trial status changed: Recruiting → Withdrawn
Trial withdrawn: funding issue
Primary completion confirmed: September 2026 (last estimated September 2029)
Start date pushed: 2021-09-16 → 2026-09-13
624 trials monitored
See 9 trials at risk
5,180 trials monitored
See 256 trials at risk
This non-inferiority, phase 3 clinical trial evaluates the cosmetic non-inferiority of a one-week regimen (26 Gy/5 Fx) versus a three-week regimen (40 Gy/15 Fx) using intensity-modulated radiation therapy (IMRT) for partial breast irradiation (PBI) in low-risk breast cancer patients post-breast-conserving surgery. It also compares secondary outcomes including efficacy, safety, and quality of life between the two groups.
Trial Details
NCT Number NCT07814365
Lead Sponsor Fudan University
Conditions Early-Stage Breast Cancer
Start Date 2026-09-13
Primary Completion 2026-09-13 (estimated)
Study Completion 2026-09-13 (estimated)
Updated on ClinicalTrials.gov 2026-09-16